Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Gross Margin: 2016-2024

Historic Gross Margin for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to 59.76%.

  • Collegium Pharmaceutical's Gross Margin rose 94.00% to 61.70% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.22%, marking a year-over-year decrease of 514.00%. This contributed to the annual value of 59.76% for FY2024, which is 221.00% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Gross Margin is 59.76%, which was up 3.84% from 57.55% recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Gross Margin ranged from a high of 59.76% in FY2024 and a low of 45.15% during FY2022.
  • For the 3-year period, Collegium Pharmaceutical's Gross Margin averaged around 54.15%, with its median value being 57.55% (2023).
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 2,328bps in 2020, then tumbled by 925bps in 2022.
  • Collegium Pharmaceutical's Gross Margin (Yearly) stood at 58.01% in 2020, then plummeted by 361bps to 54.40% in 2021, then tumbled by 925bps to 45.15% in 2022, then surged by 1,239bps to 57.55% in 2023, then skyrocketed by 221bps to 59.76% in 2024.